Contact Us
Point Of Care Hematology Diagnostics Global Market Report 2025
Global Point Of Care Hematology Diagnostics Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Point Of Care Hematology Diagnostics Global Market Report 2025

By Type (Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types), By Product (Consumables, Systems), By Mode Of Prescription (Prescription Based Product, Over-The-Counter Based Product), By End User (Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Point Of Care Hematology Diagnostics Market Overview

• Point Of Care Hematology Diagnostics market size has reached to $2.66 billion in 2024

• Expected to grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%

• Growth Driver: Increasing Prevalence Of Blood Disorders Fueling The Growth Of The Market Due To Rising Chronic Disease Incidence And Need For Timely Monitoring

• Market Trend: Artificial Intelligence-Powered Cartridge System Transforms On-Site Blood Analysis

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point Of Care Hematology Diagnostics Market?

Point of care hematology diagnostics refers to medical tests conducted at or near the site of patient care to quickly assess blood-related conditions, such as anemia, infections, or clotting disorders. These tests provide rapid, accurate hematological results to support timely clinical decisions, especially in emergency or resource-limited settings. This approach reduces the need for centralized laboratory testing and accelerates diagnosis and treatment.

The main types of point-of-care hematology diagnostics are complete blood count, coagulation testing, hemoglobin testing, anemia diagnosis, and others. A complete blood count (CBC) is a blood test that measures various components of blood, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, to help evaluate overall health and detect a wide range of disorders. These diagnostics are available in products as consumables and systems. The different modes of prescription include both prescription-based and over-the-counter-based products, catering to various end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and others.

Point Of Care Hematology Diagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Point Of Care Hematology Diagnostics Market Size 2025 And Growth Rate?

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to the rising prevalence of hematological disorders, the rise in decentralized healthcare settings, the increasing focus on early disease detection, rising healthcare expenditures in emerging markets, and the increasing use of portable diagnostic devices.

What Is The Point Of Care Hematology Diagnostics Market Growth Forecast?

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing demand for immediate clinical decisions, growing demand for home healthcare diagnostics, increasing prevalence of blood-related disorders, and rising awareness about preventive healthcare. Major trends in the forecast period include advanced connectivity features in hematology analyzers, innovation in sample preparation methods, integration of artificial intelligence in diagnostic tools, innovation in single-cell analysis, integration of cloud-based data platforms, and advancement in lab-on-a-chip solutions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Point Of Care Hematology Diagnostics Market Segmented?

1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types

2) By Product: Consumables, Systems

3) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product

4) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users

Subsegments:

1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)

2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level

3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin

4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation

5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, c-reactive protein testing

What Is Driving The Point Of Care Hematology Diagnostics Market? Increasing Prevalence Of Blood Disorders Fueling The Growth Of The Market Due To Rising Chronic Disease Incidence And Need For Timely Monitoring

The increasing prevalence of blood disorders is expected to propel the growth of the point-of-care hematology diagnostics market going forward. Blood disorders refer to conditions that affect the components of blood, including red blood cells, white blood cells, platelets, or plasma. The increasing incidence of blood disorders is primarily due to the rising prevalence of chronic diseases, which directly impact blood health and require ongoing monitoring. Point-of-care hematology diagnostics help in the timely detection and monitoring of blood disorders by providing rapid, accurate results at or near the site of patient care, enabling quicker clinical decisions and improved disease management. For instance, in April 2024, according to the Perth Blood Institute, an Australia-based non-profit organization, the number of people identified with hemophilia (a genetic blood disorder where blood lacks proper clotting factors, causing prolonged bleeding) reached 257,146 in 2022, rising from 233,577 in 2021. Therefore, the rising incidence of blood disorders is driving the growth of the point-of-care hematology diagnostics market.

Who Are The Major Players In The Global Point Of Care Hematology Diagnostics Market?

Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.

What Are The Key Trends Of The Global Point Of Care Hematology Diagnostics Market? Artificial Intelligence-Powered Cartridge System Transforms On-Site Blood Analysis

Major companies operating in the point-of-care hematology diagnostics market are focusing on developing technologically advanced products, such as cartridge-based AI-powered hematology analyzers, to deliver rapid, accurate, and on-site blood analysis for improved patient care. Cartridge-based AI-powered hematology analyzers are compact diagnostic devices that use single-use reagent cartridges and artificial intelligence algorithms to quickly and accurately analyze blood samples at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer designed for veterinary use. This innovative system delivers rapid, reference laboratory-quality complete blood count (CBC) results within minutes at the point of care, while reducing maintenance and hands-on time. It is equipped with advanced AI-driven image analysis and viscoelastic focusing technology that precisely aligns cells for clear imaging, enabling accurate blood cell classification and automated abnormality detection, thereby ensuring efficient and reliable veterinary diagnostics.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market? Mars Strengthens Point-Of-Care Hematology Through Heska Deal

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. With this acquisition, Mars Inc. aims to expand its veterinary diagnostics capabilities and strengthen its position in advanced animal healthcare through Heska’s innovative diagnostic and specialty solutions. Heska Corporation is a US-based veterinary diagnostics company offering point-of-care (POC) hematology diagnostics.

What Is The Regional Outlook For The Global Point Of Care Hematology Diagnostics Market?

North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Point Of Care Hematology Diagnostics Market?

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Point Of Care Hematology Diagnostics Industry?

The point of care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point of care hematology diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Point Of Care Hematology Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.90 billion
Revenue Forecast In 2034 $4.05 billion
Growth Rate CAGR of 8.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Type, Product, Mode Of Prescription, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Point Of Care Hematology Diagnostics Market Characteristics

3. Point Of Care Hematology Diagnostics Market Trends And Strategies

4. Point Of Care Hematology Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Hematology Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Point Of Care Hematology Diagnostics Market Growth Rate Analysis

5.4. Global Point Of Care Hematology Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Point Of Care Hematology Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM)

6. Point Of Care Hematology Diagnostics Market Segmentation

6.1. Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Complete Blood Count

Coagulation Testing

Hemoglobin Testing

Anemia Diagnosis

Other Types

6.2. Global Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consumables

Systems

6.3. Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prescription Based Product

Over-The-Counter Based Product

6.4. Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Centers

Hospitals

Blood Banks

Transfusion Centers

Other End Users

6.5. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

White Blood Cell Count

Red Blood Cell Count

Platelet Count

Hematocrit

Hemoglobin Concentration

Mean Corpuscular Volume (MCV)

6.6. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prothrombin Time (PT)

Activated Partial Thromboplastin Time (aPTT)

International Normalized Ratio (INR)

D-Dimer Test

Fibrinogen Level

6.7. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Total Hemoglobin

Glycated Hemoglobin (HbA1c)

Oxyhemoglobin

Carboxyhemoglobin

Methemoglobin

6.8. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Iron Studies

Vitamin B12 Levels

Folate Levels

Reticulocyte Count

Ferritin Test

Transferrin Saturation

6.9. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Typing And Crossmatching

Erythrocyte Sedimentation Rate

Malaria Parasite Detection

Sickle Cell Screening

C-reactive Protein Testing

7. Point Of Care Hematology Diagnostics Market Regional And Country Analysis

7.1. Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Hematology Diagnostics Market

8.1. Asia-Pacific Point Of Care Hematology Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Hematology Diagnostics Market

9.1. China Point Of Care Hematology Diagnostics Market Overview

9.2. China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Hematology Diagnostics Market

10.1. India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Hematology Diagnostics Market

11.1. Japan Point Of Care Hematology Diagnostics Market Overview

11.2. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Hematology Diagnostics Market

12.1. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Hematology Diagnostics Market

13.1. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Hematology Diagnostics Market

14.1. South Korea Point Of Care Hematology Diagnostics Market Overview

14.2. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Hematology Diagnostics Market

15.1. Western Europe Point Of Care Hematology Diagnostics Market Overview

15.2. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Hematology Diagnostics Market

16.1. UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Hematology Diagnostics Market

17.1. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Hematology Diagnostics Market

18.1. France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Hematology Diagnostics Market

19.1. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Hematology Diagnostics Market

20.1. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Hematology Diagnostics Market

21.1. Eastern Europe Point Of Care Hematology Diagnostics Market Overview

21.2. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Hematology Diagnostics Market

22.1. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Hematology Diagnostics Market

23.1. North America Point Of Care Hematology Diagnostics Market Overview

23.2. North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Hematology Diagnostics Market

24.1. USA Point Of Care Hematology Diagnostics Market Overview

24.2. USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Hematology Diagnostics Market

25.1. Canada Point Of Care Hematology Diagnostics Market Overview

25.2. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Hematology Diagnostics Market

26.1. South America Point Of Care Hematology Diagnostics Market Overview

26.2. South America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Hematology Diagnostics Market

27.1. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Hematology Diagnostics Market

28.1. Middle East Point Of Care Hematology Diagnostics Market Overview

28.2. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Hematology Diagnostics Market

29.1. Africa Point Of Care Hematology Diagnostics Market Overview

29.2. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Hematology Diagnostics Market Competitive Landscape And Company Profiles

30.1. Point Of Care Hematology Diagnostics Market Competitive Landscape

30.2. Point Of Care Hematology Diagnostics Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Hematology Diagnostics Market Other Major And Innovative Companies

31.1. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

31.2. Sysmex Corporation

31.3. HORIBA Ltd.

31.4. Nova Biomedical Corp.

31.5. S.D. Sight Diagnostics Ltd.

31.6. EKF Diagnostics Holdings plc.

31.7. Medsource Ozone Biomedicals Pvt. Ltd.

31.8. BioSystems S.A.

31.9. Chengdu Seamaty Technology Co. Ltd.

31.10. Drucker Diagnostics LLC

31.11. Diamond Diagnostics Inc.

31.12. DIAGON Kft.

31.13. BioMedomics Inc.

31.14. Norma Instruments Zrt.

31.15. PixCell Medical Technologies Ltd.

32. Global Point Of Care Hematology Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market

34. Recent Developments In The Point Of Care Hematology Diagnostics Market

35. Point Of Care Hematology Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Point Of Care Hematology Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Point Of Care Hematology Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Point Of Care Hematology Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Abbott Laboratories Financial Performance
  • Table 83: Danaher Corporation Financial Performance
  • Table 84: Siemens Healthineers AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Abbott Laboratories Financial Performance
  • Figure 83: Danaher Corporation Financial Performance
  • Figure 84: Siemens Healthineers AG Financial Performance

Frequently Asked Questions

Point of care hematology diagnostics refers to medical tests conducted at or near the site of patient care to quickly assess blood-related conditions, such as anemia, infections, or clotting disorders. These tests provide rapid, accurate hematological results to support timely clinical decisions, especially in emergency or resource-limited settings. This approach reduces the need for centralized laboratory testing and accelerates diagnosis and treatment. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Blood Disorders Fueling The Growth Of The Market Due To Rising Chronic Disease Incidence And Need For Timely Monitoring. For further insights on this market, request a sample here

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to the rising prevalence of hematological disorders, the rise in decentralized healthcare settings, the increasing focus on early disease detection, rising healthcare expenditures in emerging markets, and the increasing use of portable diagnostic devices. The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing demand for immediate clinical decisions, growing demand for home healthcare diagnostics, increasing prevalence of blood-related disorders, and rising awareness about preventive healthcare. Major trends in the forecast period include advanced connectivity features in hematology analyzers, innovation in sample preparation methods, integration of artificial intelligence in diagnostic tools, innovation in single-cell analysis, integration of cloud-based data platforms, and advancement in lab-on-a-chip solutions. For further insights on this market, request a sample here

The point of care hematology diagnostics market covered in this report is segmented
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Product: Consumables, Systems
3) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
4) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing For further insights on this market,
request a sample here

North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Artificial Intelligence-Powered Cartridge System Transforms On-Site Blood Analysis. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon